Shanghai, China

Hong Shen

USPTO Granted Patents = 42 

 

 

Average Co-Inventor Count = 6.9

ph-index = 6

Forward Citations = 108(Granted Patents)


Location History:

  • West Windsor, NJ (US) (2012 - 2016)
  • Pudong, CN (2015 - 2016)
  • Shanghai, CN (2010 - 2024)

Company Filing History:


Years Active: 2010-2025

where 'Filed Patents' based on already Granted Patents

42 patents (USPTO):

Title: An Overview of Hong Shen’s Innovative Contributions in Patent Development

Introduction

Hong Shen, based in Shanghai, China, is an accomplished inventor with an impressive portfolio of 38 patents. His work primarily focuses on novel compounds that address significant medical challenges, particularly in the field of autoimmune diseases. With a solid background in pharmaceutical research, Hong Shen has made notable strides in innovation.

Latest Patents

Among his latest contributions are groundbreaking patents involving Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds designed for the treatment of autoimmune diseases. The invention outlines compounds of specific formulas, detailing various acceptable salts, enantiomers, and diastereomers, along with methods for their use. In addition, he has developed peptide macrocycles that hold promise against various medical conditions, further illustrating his innovation in pharmaceutical compounds.

Career Highlights

Hong Shen has worked with prominent pharmaceutical companies, including Hoffmann-La Roche Inc. and Merck Sharp & Dohme Corporation. His role in these organizations showcases his commitment to advancing medical research and enhancing therapeutic options through innovative discoveries.

Collaborations

Throughout his career, Hong Shen has collaborated with talented individuals such as Taishan Hu and Zhisen Zhang. These partnerships have facilitated knowledge exchange and spurred the development of new ideas, reinforcing the essence of teamwork in the realm of scientific innovation.

Conclusion

In summary, Hong Shen stands out as a significant contributor to the field of invention and patent development. His commitment to innovation and collaboration continues to drive advancements in medical research, undoubtedly paving the way for future solutions to complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…